Today: 7 February 2026
Subscribe

Fastenal (FAST) Stock on 14 November 2025: New CFO, Barclays Price Target Cut to $44, and Fresh Undervaluation Debate

Fastenal (FAST) Stock on 14 November 2025: New CFO, Barclays Price Target Cut to $44, and Fresh Undervaluation Debate

Fastenal Company (NASDAQ: FAST) is under the spotlight again as investors digest a wave of fresh headlines: a new analysis arguing the stock may be potentially undervalued, a new chief financial officer stepping in, multiple analyst downgrades and price-target cuts, plus big institutional and insider buying in the background. Investing.com UK+4Yahoo Finance+4Fastenal Investor+4 With shares recently trading around the low‑$40s and about 19% below their 52‑week high, Fastenal is becoming a battleground name for dividend and quality‑growth investors heading into year‑end. MarketBeat+1 Where Fastenal’s stock stands today Fastenal shares are hovering just under $41 and have pulled back from a
14 November 2025
·
Social Security Surprise: No SSI Check on Nov. 1 – See Why Your Payment Arrives Early

IRS Direct Deposit Stimulus Check in November 2025? Fact Check on $1,390, $2,000 Relief Payments, DOGE Checks and Trump’s Tariff Dividend

Updated: November 14, 2025 Searches for “IRS stimulus check,” “IRS direct deposit relief payment,” and “stimulus payment November 2025” have exploded again — helped along by viral posts promising $1,390, $1,702, or even $2,000 hitting bank accounts via direct deposit IRS this month. Here’s the bottom line as of November 14, 2025: Below is a detailed, up‑to‑date guide to what’s actually happening with IRS stimulus payments, direct deposit, federal stimulus checks, Trump’s 2025 stimulus ideas and DOGE checks — and how to protect yourself from scams. 1. Stimulus Payment November 2025: What the IRS Has Actually Said Despite headlines and
14 November 2025
Caterpillar (CAT) Stock Today: Wells Fargo Starts at Overweight as Volume Momentum Builds — November 14, 2025

Caterpillar (CAT) Stock Today: Wells Fargo Starts at Overweight as Volume Momentum Builds — November 14, 2025

On Friday, November 14, 2025, investors in Caterpillar Inc. (NYSE: CAT) are digesting a wave of fresh analyst commentary, insider and institutional activity, and a detailed new look at the company’s improving volume trends — all against the backdrop of a bruising week for global equities. Caterpillar shares closed Thursday at about $553.55, down roughly 3.4% on the day as part of a broad market selloff that saw the Dow Jones Industrial Average shed nearly 800 points.StockAnalysis+1 A pre‑market update from MarketWatch early Friday showed CAT essentially flat around $553–554, suggesting investors are pausing to reassess after the sharp pullback.MarketWatch
14 November 2025
DeFi Technologies (DEFT) Q3 2025: Revenue Miss, New CEO, Guidance Cut

DeFi Technologies (DEFT) Q3 2025: Revenue Miss, New CEO, Guidance Cut

DeFi Technologies Inc. (Nasdaq: DEFT; CBOE CA: DEFI; GR: R9B), the Nasdaq‑listed digital asset manager bridging traditional finance and decentralized finance (DeFi), reported third‑quarter 2025 results on Friday that combined solid profitability with a sharp revenue miss, a steep guidance cut — and a major change in leadership at the top. PR Newswire+1 The company also announced that co‑founder Johan Wattenström will become Chief Executive Officer and Executive Chairman, replacing Olivier Roussy Newton, who is stepping down from those roles but staying on as a cornerstone shareholder, partner and advisor. PR Newswire+1 Key takeaways for DeFi Technologies (DEFT) today Q3
14 November 2025
···
Binah Capital Group (BCG) Jumps on Q3 2025 Earnings Beat as AUM Hits $30 Billion

Binah Capital Group (BCG) Jumps on Q3 2025 Earnings Beat as AUM Hits $30 Billion

Binah Capital Group, Inc. (NASDAQ: BCG) is back in the spotlight today after releasing stronger‑than‑expected third‑quarter 2025 results and triggering a sharp move in its thinly traded stock. After the company reported double‑digit revenue growth, expanding margins, and a swing to GAAP profitability for the year to date, BCG shares spiked as much as ~75% in after‑hours trading on Thursday and continued to trade significantly higher in pre‑market action on Friday, November 14.StockAnalysis+2Benzinga+2 Today’s key Binah Capital Group headlines (14 November 2025) As of Friday, November 14, 2025, the main developments around Binah Capital Group are: All of this marks
14 November 2025
·
Luxembourg Goes Full Bitcoin: First Eurozone Sovereign Wealth Fund Puts 1% Into BTC as Europe Tests Central Bank Crypto

Luxembourg Goes Full Bitcoin: First Eurozone Sovereign Wealth Fund Puts 1% Into BTC as Europe Tests Central Bank Crypto

Luxembourg’s 1% Bitcoin Bet: Small Slice, Huge Signal Luxembourg has confirmed that its Intergenerational Sovereign Wealth Fund (FSIL) now holds 1% of its portfolio in Bitcoin, roughly €7 million out of about €700–730 million in assets. coinpaprika.com+2Luxembourg for Finance+2 The move stems from a July 2025 policy revision that lets FSIL allocate up to 15% of its holdings to “alternative investments” such as private equity, real estate, and digital assets. Bitcoin is the first crypto asset to make the cut. Luxembourg for Finance+2Goodwin Law Firm+2 According to official and legal briefings: In other words, Luxembourg hasn’t gone “all‑in” on BTC
14 November 2025
··
Bloom Energy (BE) Stock Tumbles After 343% Rally: AI Power, Leveraged ETF and Big-Money Moves on November 14, 2025

Bloom Energy (BE) Stock Tumbles After 343% Rally: AI Power, Leveraged ETF and Big-Money Moves on November 14, 2025

Bloom Energy Corporation (NYSE: BE), one of 2025’s hottest AI-and-clean-energy stories, is back in the spotlight today after a violent mid‑week sell‑off, the launch of a new 2x leveraged ETF, and fresh institutional trading disclosures. The stock remains up massively for the year – but the mood around BE has shifted from euphoria to uneasy volatility. Bloom Energy stock today: from moonshot to whipsaw According to new analysis published this morning, Bloom Energy shares are still up about 343% year‑to‑date and nearly 680% over the past 12 months, even after a steep pullback of more than 24% in the last
14 November 2025
··
Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (NASDAQ: XPON) stock jumped more than 28% after hours as the lithium-ion battery maker posted a surprise Q3 2025 profit, crushed earnings estimates, and highlighted its new leadership team Quick Takeaways XPON Stock: Big After-Hours Pop, Still Deep in the Red Year-Over-Year Expion360 Inc. (NASDAQ: XPON), a maker of premium lithium iron phosphate (LiFePO₄) batteries for RV, marine and home energy storage, saw its stock jump 28.35% in after-hours trading on November 14, climbing to $1.63 after closing Thursday’s regular session at $1.27. Benzinga As of early afternoon trading on November 14, 2025, XPON is hovering around $1.27, giving
14 November 2025
···
SoFi Technologies (SOFI) News Today – November 14, 2025: Fresh THTA Dividend, Pension-Fund Buying and New Long‑Term Price Targets

SoFi Technologies (SOFI) News Today – November 14, 2025: Fresh THTA Dividend, Pension-Fund Buying and New Long‑Term Price Targets

SoFi Technologies, Inc. (NASDAQ: SOFI) is back in the headlines today with a fresh monthly distribution on its high‑yield SoFi Enhanced Yield ETF (THTA), new disclosures on institutional buying, and a fresh long‑term stock forecast that sees nearly 95% upside by 2030. GlobeNewswire+2MarketBeat+2 At the same time, recent filings show the company’s chief financial officer has monetized part of his stake via a prepaid variable forward contract, while options activity and crypto expansion keep SoFi squarely in the market’s spotlight. Stock Titan+2Futunn News+2 Below is a full rundown of everything new and market‑moving around SoFi as of November 14, 2025.
14 November 2025
·
Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

Billionaire investor Ron Baron is once again staking his reputation — and a huge chunk of his fortune — on Elon Musk. In a fresh appearance on CNBC’s Squawk Box this morning, Baron said he does not expect to sell his personal Tesla (TSLA) or SpaceX shares during his lifetime, underscoring just how long-term his conviction really is. The interview, which is being widely syndicated through outlets including MSN and YouTube, also touched on the broader stock market, Musk’s record-breaking $1 trillion Tesla pay package, and what investors can expect from today’s 32nd Annual Baron Investment Conference in New York.
14 November 2025
···
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. (NYSE: HIMS) is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich valuations, insider selling and tighter 2025 guidance. Investing.com+4Hims Investors+4Investing.com Australia+4 HIMS stock today: price, move and context As of early afternoon on Friday, November 14, 2025, Hims & Hers shares are: Trading has been volatile around HIMS in recent sessions,
14 November 2025
·
Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug

Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug

Anavex Life Sciences (NASDAQ: AVXL) tumbled on November 14, 2025 after Europe’s drug regulator delivered a negative trend vote on its Alzheimer’s candidate blarcamesine. The company plans a CHMP re-examination and a fresh meeting with the FDA. Here’s what happened and what comes next. By Staff Reporter — November 14, 2025 NEW YORK — Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) were under heavy pressure on Friday after the European Medicines Agency’s human medicines committee signaled it is leaning against approving the company’s experimental Alzheimer’s pill blarcamesine for early Alzheimer’s disease. Investing News Network (INN)+1 The Committee for Medicinal
14 November 2025
··
1 … 2,182 2,183 2,184 2,185 2,186 … 2,714

Stock Market Today

Go toTop